- $37.12m
- $124.97m
- $182.60m
- 59
- 86
- 52
- 72
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.15 | ||
| Price to Tang. Book | 0.16 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.2 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -17.22% | ||
| Return on Equity | -25.14% | ||
| Operating Margin | -31.42% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 932.41 | 968.92 | 615.68 | 352.86 | 182.6 | 212.04 | 236.38 | -26.33% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -69.39 | -18.84 | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Zepp Health Corp, formerly Huami Corp, is a company committed to connect health with technology. It has developed a platform of proprietary technology including artificial intelligence (AI) chips, biometric sensors, and health data algorithms. It is engaged in developing smart wearable technology. It designs and develops biometric and activity data-driven fitness and smart watches. It markets its products under the brand name, Amazfit and is the sole partner for Xiaomi wearable products. The products includes Amazfit BIP, Amazfit pace, Amazfit equator, Amazfit ARC, and accessories, such as sports bands, watch straps, ear buds, charging units, and core trackers. The smart watches provides activity tracking, sleep tracking, smart notifications from mobile devices, GPS, heart rate sensing, water resistance, wireless syncing with mobile phones. It also provides a mobile application to keep track of the fitness information, set alarms and receive call notifications on the smart watch.
Directors
- Wang Huang CHM (44)
- Leon Cheng Deng CFO (38)
- Mike Yeung COO (49)
- Meihui Fan CTO
- Hui Wang VPR (43)
- Pengtao Yu OTH (38)
- De Liu DRC (46)
- Yunfen Lu DRC (54)
- Xiaojun Zhang DRC (48)
- Jimmy Lai IND (63)
- Bing Xie IND (53)
- Hongjiang Zhang IND
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 1st, 2014
- Public Since
- February 8th, 2018
- No. of Employees
- 839
- Sector
- Computers, Phones & Household Electronics
- Industry
- Technology
- Exchange
New York Stock Exchange- Shares in Issue
- 232,000,000
- Address
- Building B2, Zhong'an Chuanggu, HEFEI, 230088
- Web
- https://www.huami.com
- Phone
- +86 55165837200
- Contact
- Grace Zhang
- Auditors
- Deloitte Touche Tohmatsu CPA LLP
Upcoming Events for ZEPP
Q2 2025 Zepp Health Corp Earnings Release
Similar to ZEPP
Dell Technologies
New York Stock Exchange
Diebold Nixdorf
New York Stock Exchange
Hewlett Packard Enterprise Co
New York Stock Exchange
HP
New York Stock Exchange
Pure Storage
New York Stock Exchange
FAQ
What is the Zepp Health share price?
As of Today at 24:15 UTC, shares in Zepp Health are trading at $2.56. This share price information is delayed by 15 minutes.
How has the Zepp Health share price performed this year?
Shares in Zepp Health last closed at $2.56 and the price had moved by -22.48% over the past 365 days. In terms of relative price strength the Zepp Health share price has underperformed the S&P500 Index by -27.11% over the past year.
What are the analyst and broker recommendations for Zepp Health?
The overall consensus recommendation for Zepp Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Zepp Health dividend yield?
Zepp Health does not currently pay a dividend.
Does Zepp Health pay a dividend?
Zepp Health does not currently pay a dividend.
When does Zepp Health next pay dividends?
Zepp Health does not currently pay a dividend.
How do I buy Zepp Health shares?
To buy shares in Zepp Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Zepp Health?
As of the previous close price of $2.56, shares in Zepp Health had a market capitalisation of $37.12m.
Where are Zepp Health shares listed?
Here are the trading details for Zepp Health:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: ZEPP
What kind of share is Zepp Health?
Based on an overall assessment of its quality, value and momentum Zepp Health is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Zepp Health share price forecast for 2025?
The analyst consensus target price for shares in Zepp Health is $13.88. That is 442.2% above the last closing price of $2.56.
Analysts covering Zepp Health currently have a consensus Earnings Per Share (EPS) forecast of -$0.08 for the next financial year.
Find out moreWhat is the trend in the Zepp Health share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Zepp Health. Over the past six months, its share price has underperformed the S&P500 Index by -21.63%.
As of the last closing price of $2.56, shares in Zepp Health were trading -13.57% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Zepp Health PE Ratio?
The Zepp Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $2.56.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Zepp Health?
Zepp Health's management team is headed by:
- Wang Huang - CHM
- Leon Cheng Deng - CFO
- Mike Yeung - COO
- Meihui Fan - CTO
- Hui Wang - VPR
- Pengtao Yu - OTH
- De Liu - DRC
- Yunfen Lu - DRC
- Xiaojun Zhang - DRC
- Jimmy Lai - IND
- Bing Xie - IND
- Hongjiang Zhang - IND